Riskpilot← Back to searchSign inGet full accessSENTRUM ØRE NESE HALS AS
ASActiveOrg 998902320Tullins gate 6, 0166 OsloGeneral medical practice activities · NACE 8621Est. 20125 employees
Revenue 2025
NOK 9M
+1% vs 2024
EBITDA margin
32.9%
-3% vs 2024
Equity ratio
2.4%
Financial strength
Net profit 2025
NOK 2,3M
-2% vs 2024
| Revenue | NOK 9M | +1% |
| EBITDA | NOK 3M | -3% |
| Net profit | NOK 2,3M | -2% |
| Total assets | NOK 4,2M | +3% |
| Equity | NOK 102K | -5% |
| Employees | 5 | — |
Legal name
SENTRUM ØRE NESE HALS AS
Org number
998902320
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. oktober 2012
Share capital
NOK 100 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet og det som naturlig følger slik virksomhet. Det skal være anledning til å eie, leie og fremleie fast eiendom. Det skal også være anledning til å eie aksjer og andeler i andre selskaper.
Address
Tullins gate 6, 0166 Oslo
Phone
+4722113739
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 509 | 8 086 | 8 602 | 8 938 | 9 031 |
| Staff expenses | −3 790 | −4 014 | −4 371 | −4 633 | −4 781 |
| EBITDA | 2 670 | 3 066 | 2 821 | 3 063 | 2 974 |
| Depreciation & amort. | −164 | −91 | −79 | −82 | −45 |
| EBIT | 2 506 | 2 975 | 2 742 | 2 981 | 2 928 |
| Net financials | −2 | 0 | 10 | 40 | 36 |
| Profit before tax | 2 504 | 2 975 | 2 752 | 3 021 | 2 964 |
| Tax | 551 | 655 | 605 | 665 | 652 |
| Net profit | 1 953 | 2 321 | 2 146 | 2 356 | 2 312 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 578 | 3 887 | 3 756 | 4 081 | 4 195 |
| Equity | 100 | 101 | 101 | 107 | 102 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 478 | 3 786 | 3 655 | 3 974 | 4 093 |
| Total debt | 3 478 | 3 786 | 3 655 | 3 974 | 4 093 |
EBITDA margin
32.9%
This company
15.8%
Market median
+108% vs market
20212025
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20212025
Return on equity
2272.7%
This company
18.4%
Market median
+12252% vs market
20212025
Net profit margin
25.6%
This company
8.1%
Market median
+216% vs market
20212025
Asset turnover
2.15×
This company
1.12×
Market median
+92% vs market
20212025
Debt / equity
40.24×
This company
0.62×
Market median
-6390% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Sævarsson Helse As
SENTRUM ØRE NESE HALS AS Board members of SENTRUM ØRE NESE HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Moeidur Bernhardsdottir | Chief Executive Officer | 0 companies |
| Thorarinn Örn Sævarsson | Chairman | 0 companies |